UPDATE: BMO Capital Downgrades Akcea Therapeutics, Inc. (AKCA) to Market Perform

Go back to UPDATE: BMO Capital Downgrades Akcea Therapeutics, Inc. (AKCA) to Market Perform

Form SC 13D/A AKCEA THERAPEUTICS, INC. Filed by: IONIS PHARMACEUTICALS INC

August 31, 2020 7:13 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

... More

Form SC TO-C AKCEA THERAPEUTICS, INC. Filed by: IONIS PHARMACEUTICALS INC

August 31, 2020 7:08 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More